Healthcare cybersecurity has never been so complicated—or so plannable

Hospitals have always had to rely on multitudes of healthcare vendors to keep operations humming. In recent years the arrangement’s inherent management challenge has only grown more complex. 

That’s largely because myriad AI technologies have changed daily life for provider organizations and industry partners alike. Arguably the biggest single difficulty to emerge from the transformation is the risk of cybersecurity breaches. 

The Health Sector Coordinating Council (HSCC) is taking a crack at helping cybersecurity leaders, teams and stakeholders clear a path through the thicket. The assistance comes in the form of a 109-page document titled Third-Party AI Risk and Supply Chain Transparency Guide.

The guidebook is authored by members of an HSCC working group focused on cybersecurity. The team’s guiding aim for the project was to “address the growing gaps in discovery and disclosure processes that make AI supply chain risk so difficult to manage.”

Pointing out that many healthcare organizations operate with incomplete or outdated vendor inventories, working group co-leaders Ed Gaudet of Censinet and Samantha Jacques of McLaren Health, along with 16 named co-authors, note the commonality of AI-specific cybersecurity risks going unreported. 

As examples of such risks, they name synthetic data misuse, training data leakage and adversarial inference.

“The healthcare sector’s accelerating adoption of artificial intelligence has expanded its dependence on third-party tools and services, introducing complex cybersecurity challenges that traditional risk management tools and models struggle to address,” the team writes in a foreword. “Compounding the risk, healthcare organizations often lack visibility into the full scope of AI components sourced through layered supply chains. This opacity elevates systemic exposure and risk, further complicating response coordination in the event of a breach or model failure.”

Playbook for prevention, response and winddown   

In the body of the guide, the cybersecurity subgroup walks the reader through a planned lifecycle for managing risks related to third-party AI players involved with the provider enterprise. 

The document breaks the lifecycle into seven distinct yet overlapping phases, as follows. 

Phase 0—AI use case justification and strategic assessment.

Define the problem, confirm AI suitability, classify the use case by safety impact (low, medium, high or critical). Establish accountability to ensure strategic alignment and an understood risk profile.
 

Phase 1—Due diligence and vendor evaluation.

Extend standard vendor assessment (financial, cybersecurity) with AI-specific governance, risk and compliance (GRC) assessments. Key areas include data lineage/bias, model transparency/explainability, security controls, supply chain dependencies and ethical practices. Assessment rigor must scale based on the risk classification from Phase 0, and vendors must provide quality assurance, verification and validation (QA/VV) documentation.
 

Phase 2—Contract negotiation and legal protections. 

Standard agreements are insufficient for AI. This phase establishes shared responsibility through AI-specific contract clauses covering data ownership, training restrictions, change approval, performance obligations, incident response and end-of-life support. Enhanced business associate agreement (BAA) provisions address the unique risks of processing protected health information (PHI) with AI.
 

Phase 3—Implementation, integration and training. 

Covers the highest-risk transition to production. Conduct AI-specific threat modeling (e.g., OWASP Top 10 for LLMs), rigorous sandbox/clinical validation and security testing. Ensure role-specific training is completed for all staff and utilize phased production rollout with enhanced monitoring.
 

Phase 4—Ongoing monitoring and performance management.

This is the longest phase. It requires continuous attention to model drift, bias, performance degradation and security integrity, especially after vendor updates. It encompasses security/compliance auditing, patch validation and periodic reassessment. Quality assurance and re-validation are essential after every system change.
 

Phase 5—Incident response and recovery.

Prepares for inevitable AI incidents (model degradation, breaches, bias events). Establish detection, classification, containment, vendor coordination protocols, model rollback/revalidation and post-incident corrective actions. AI incidents are uniquely gradual and difficult to detect, requiring specialized forensics and vendor expertise.
 

Phase 6—End-of-life and transition management.

Addresses planned and unplanned AI discontinuation. Proactive planning ensures continuity of care, secure data destruction and regulatory compliance, managing unique challenges like embedded organizational data and replacement system revalidation.

“Healthcare’s rapid AI adoption demands a fundamental shift in managing third-party technology risk,” the authors comment. “Traditional vendor risk practices fail to address AI systems that learn, drift and rely on opaque supply chains. This Guide provides a structured, lifecycle-based framework for healthcare organizations to mitigate risks, ensuring AI delivers value without compromising patient safety, data privacy or operational continuity.”

The guide is available in full for free.